Pre-publication history
Does atenolol differ from other β-adrenergic blockers?
-
* Corresponding author: Ivar Aursnes i.a.aursnes@medisin.uio.no
BMC Clinical Pharmacology 2007, 7:4 doi:10.1186/1472-6904-7-4
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 14 Feb 2006 | |
| Reviewer's Report | Luis Ruilope | 08 May 2006 | |
| Reviewer's Report | Steven Belknap | 18 Jul 2006 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 08 Aug 2006 |
| Resubmission - Version 3 | Manuscript | Author's comment | 08 Aug 2006 |
| Reviewer's Report | Steven Belknap | 12 Aug 2006 | |
| Reviewer's Report | Elja Arjas | 21 Mar 2007 | |
| Resubmission - Version 4 | Manuscript | Author's comment | 01 Apr 2007 |
| Resubmission - Version 5 | Manuscript | 01 Apr 2007 | |
| Resubmission - Version 6 | Manuscript | Author's comment | 10 Apr 2007 |
| Editorial acceptance | 19 Apr 2007 | ||
| Published | 08 May 2007 |